JP2015530875A5 - - Google Patents

Download PDF

Info

Publication number
JP2015530875A5
JP2015530875A5 JP2015524755A JP2015524755A JP2015530875A5 JP 2015530875 A5 JP2015530875 A5 JP 2015530875A5 JP 2015524755 A JP2015524755 A JP 2015524755A JP 2015524755 A JP2015524755 A JP 2015524755A JP 2015530875 A5 JP2015530875 A5 JP 2015530875A5
Authority
JP
Japan
Prior art keywords
vrna
influenza
sequence
cell
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015524755A
Other languages
English (en)
Japanese (ja)
Other versions
JP6335167B2 (ja
JP2015530875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/065920 external-priority patent/WO2014019990A1/en
Publication of JP2015530875A publication Critical patent/JP2015530875A/ja
Publication of JP2015530875A5 publication Critical patent/JP2015530875A5/ja
Application granted granted Critical
Publication of JP6335167B2 publication Critical patent/JP6335167B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015524755A 2012-08-03 2013-07-29 感染性インフルエンザウイルスの産生 Expired - Fee Related JP6335167B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305968.5 2012-08-03
EP12305968 2012-08-03
PCT/EP2013/065920 WO2014019990A1 (en) 2012-08-03 2013-07-29 Production of infectious influenza viruses

Publications (3)

Publication Number Publication Date
JP2015530875A JP2015530875A (ja) 2015-10-29
JP2015530875A5 true JP2015530875A5 (cg-RX-API-DMAC7.html) 2016-09-08
JP6335167B2 JP6335167B2 (ja) 2018-05-30

Family

ID=48900986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015524755A Expired - Fee Related JP6335167B2 (ja) 2012-08-03 2013-07-29 感染性インフルエンザウイルスの産生

Country Status (11)

Country Link
US (1) US9982240B2 (cg-RX-API-DMAC7.html)
EP (1) EP2880154B1 (cg-RX-API-DMAC7.html)
JP (1) JP6335167B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150038374A (cg-RX-API-DMAC7.html)
CN (1) CN104704112A (cg-RX-API-DMAC7.html)
AU (1) AU2013298632B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015002268A2 (cg-RX-API-DMAC7.html)
CA (1) CA2880409A1 (cg-RX-API-DMAC7.html)
MX (1) MX360120B (cg-RX-API-DMAC7.html)
SG (1) SG11201500508XA (cg-RX-API-DMAC7.html)
WO (1) WO2014019990A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105722976A (zh) * 2013-06-06 2016-06-29 诺华股份有限公司 流感病毒重配
CN104232594B (zh) * 2014-09-11 2017-05-31 中国农业科学院哈尔滨兽医研究所 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
US10927151B2 (en) 2015-06-09 2021-02-23 Sanofi Pasteur Inc. Methods of optimizing nucleotide sequences encoding engineered influenza proteins
CN105754997B (zh) * 2016-03-30 2019-02-26 华中农业大学 狂犬病毒drv-ah08株的先导rna及其在制备预防与治疗狂犬病毒的药品中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633565T3 (de) 1995-06-15 2013-01-17 Crucell Holland B.V. Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
TW389999B (en) 1995-11-21 2000-05-11 Toshiba Corp Substrate having shallow trench isolation and method of manufacturing the same
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
GB9916794D0 (en) * 1999-07-16 1999-09-22 Isis Innovation In vitro virus reconstitution
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
AU5921101A (en) 2000-04-28 2001-11-12 St Jude Childrens Res Hospital Dna transfection system for the generation of infectious influenza virus
JP4070611B2 (ja) 2001-04-23 2008-04-02 アマクサ アーゲー 電気穿孔法用の緩衝溶液およびその使用を含む方法
EP1697521B1 (en) 2003-12-23 2010-06-02 MedImmune, LLC Multi plasmid system for the production of influenza virus
US20080254065A1 (en) * 2004-03-09 2008-10-16 Chiron Corporation Influenza Virus Vaccines
ATE382085T1 (de) 2005-07-07 2008-01-15 Amaxa Ag Verfahren zur behandlung geringer volumina mit elektrischem strom
US20070111309A1 (en) 2005-10-04 2007-05-17 Daelli Marcelo G Vero cell line adapted to grow in suspension
CN100571775C (zh) * 2006-11-09 2009-12-23 中国农业科学院哈尔滨兽医研究所 禽流感病毒标记疫苗及其制备方法和应用
EP2296701A1 (en) 2008-06-11 2011-03-23 Flugen, Inc. Cell-based systems for producing influenza vaccines
KR101639454B1 (ko) 2008-07-15 2016-07-13 크루셀 홀란드 비.브이. Per.c6 세포의 배양에 대한 확장가능 방법 및 그 방법으로 생산된 산물

Similar Documents

Publication Publication Date Title
EP1631663B1 (en) High titer recombinant influenza viruses for vaccines and gene therapy
Neumann et al. Reverse genetics of influenza virus
EP2010557B1 (en) High titer recombinant influenza viruses for vaccines
CN101851636B (zh) 用于疫苗和基因治疗的重组流感病毒
US7723094B2 (en) Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy
US9580693B2 (en) Recombinant influenza viruses for vaccines and gene therapy
US8043856B2 (en) Adenoviral vectors for influenza virus production
Neumann et al. Generation of influenza A virus from cloned cDNAs—historical perspective and outlook for the new millenium
JP2016521553A5 (cg-RX-API-DMAC7.html)
JP2008525003A5 (cg-RX-API-DMAC7.html)
Kawaoka Biology of negative strand RNA viruses: the power of reverse genetics
Finch et al. Design of alternative live attenuated influenza virus vaccines
HK1082769B (en) High titer recombinant influenza viruses for vaccines and gene therapy
HK1148778B (en) Recombinant influenza viruses for vaccines and gene therapy